StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Veracyte, Inc.
NasdaqGM:VCYT
Sector
Location
Market Cap
USD 1.84 B
Share Price
USD 23.51
Avg Daily Volume
1,028,606
Change (1 day)
-2.93%
Change (1 year)
-1.75%
Change (YTD)
-40.63%
Veracyte, Inc. Enterprise Value to EBITDA (EV/EBITDA) on July 18, 2025: 32.04
Veracyte, Inc. Enterprise Value to EBITDA (EV/EBITDA) is 32.04 on July 18, 2025, a -155.21% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
-
Veracyte, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 259.59 on July 18, 2025, which is 710.24% above the current Enterprise Value to EBITDA (EV/EBITDA).
-
Veracyte, Inc. 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -86.83 on July 18, 2025, which is -371.03% below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Veracyte, Inc. average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 83.69.
Competitors
Natera, Inc.
USD 138.90
NTRA
-4.48
-3.12%
Tempus AI, Inc.
USD 60.98
TEM
+0.33
0.54%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Thermo Fisher Scientific Inc.
USD 414.75
TMO
-10.23
-2.41%
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Medtronic plc
USD 89.61
MDT
+0.08
0.09%
RELX Plc
USD 53.04
REL.L
-0.48
-0.90%
Siemens Healthineers AG
USD 53.60
SHL.DE
-0.42
-0.77%
Becton, Dickinson and Company
USD 178.85
BDX
-2.05
-1.13%
Edwards Lifesciences Corporation
USD 76.49
EW
+0.31
0.41%
IDEXX Laboratories, Inc.
USD 514.61
IDXX
-4.10
-0.79%
GE HealthCare Technologies Inc.
USD 75.96
GEHC
-0.28
-0.37%
Agilent Technologies, Inc.
USD 113.99
A
-2.37
-2.04%
DexCom, Inc.
USD 83.89
DXCM
-0.21
-0.25%
Laboratory Corporation of America Holdings
USD 243.72
LH
-3.52
-1.42%
Waters Corporation
USD 287.53
WAT
-9.39
-3.16%
bioMérieux S.A.
USD 137.64
BIM.PA
+0.47
0.34%
West Pharmaceutical Services, Inc.
USD 210.89
WST
-10.70
-4.83%
Illumina, Inc.
USD 96.14
ILMN
-1.79
-1.83%
Key Data
| Date | Enterprise Value to EBITDA (EV/EBITDA) | Free Cash Flow Yield | Dividend Yield | Market Capitalization |
|---|
Competitors
Natera, Inc.
USD 138.90
NTRA
-4.48
-3.12%
Tempus AI, Inc.
USD 60.98
TEM
+0.33
0.54%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Abbott Laboratories
USD 123.67
ABT
+3.16
2.62%
Thermo Fisher Scientific Inc.
USD 414.75
TMO
-10.23
-2.41%
Boston Scientific Corporation
USD 103.64
BSX
-1.01
-0.97%
Medtronic plc
USD 89.61
MDT
+0.08
0.09%
RELX Plc
USD 53.04
REL.L
-0.48
-0.90%
Siemens Healthineers AG
USD 53.60
SHL.DE
-0.42
-0.77%
Becton, Dickinson and Company
USD 178.85
BDX
-2.05
-1.13%
Edwards Lifesciences Corporation
USD 76.49
EW
+0.31
0.41%
IDEXX Laboratories, Inc.
USD 514.61
IDXX
-4.10
-0.79%
GE HealthCare Technologies Inc.
USD 75.96
GEHC
-0.28
-0.37%
Agilent Technologies, Inc.
USD 113.99
A
-2.37
-2.04%
DexCom, Inc.
USD 83.89
DXCM
-0.21
-0.25%
Laboratory Corporation of America Holdings
USD 243.72
LH
-3.52
-1.42%
Waters Corporation
USD 287.53
WAT
-9.39
-3.16%
bioMérieux S.A.
USD 137.64
BIM.PA
+0.47
0.34%
West Pharmaceutical Services, Inc.
USD 210.89
WST
-10.70
-4.83%
Illumina, Inc.
USD 96.14
ILMN
-1.79
-1.83%